Photo taken from Yuki Nishida/LinkedIn
Dec 7, 2023, 04:32
Yuki Nishida: This is one of the continuous efforts to overcome therapy resistance in acute myeloid leukemia by enhancing the activity of p53
Yuki Nishida, Instructor at MD Anderson Cancer Center, recently shared on LinkedIn:
“Our paper has just been published today! This is one of the continuous efforts to overcome therapy resistance in acute myeloid leukemia by enhancing the activity of p53. Thanks, Dr. Andreeff for guiding, and everyone who greatly helped this project!”
For the article click here.
Source: Yuki Nishida/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22